GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SMS Lifesciences India Ltd (BOM:540679) » Definitions » Return-on-Tangible-Equity

SMS Lifesciences India (BOM:540679) Return-on-Tangible-Equity : 13.36% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is SMS Lifesciences India Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. SMS Lifesciences India's annualized net income for the quarter that ended in Mar. 2024 was ₹236 Mil. SMS Lifesciences India's average shareholder tangible equity for the quarter that ended in Mar. 2024 was ₹1,768 Mil. Therefore, SMS Lifesciences India's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 13.36%.

The historical rank and industry rank for SMS Lifesciences India's Return-on-Tangible-Equity or its related term are showing as below:

BOM:540679' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 5.27   Med: 11.86   Max: 20.08
Current: 5.31

During the past 9 years, SMS Lifesciences India's highest Return-on-Tangible-Equity was 20.08%. The lowest was 5.27%. And the median was 11.86%.

BOM:540679's Return-on-Tangible-Equity is ranked better than
84.99% of 1306 companies
in the Biotechnology industry
Industry Median: -46.86 vs BOM:540679: 5.31

SMS Lifesciences India Return-on-Tangible-Equity Historical Data

The historical data trend for SMS Lifesciences India's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMS Lifesciences India Return-on-Tangible-Equity Chart

SMS Lifesciences India Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only 10.84 12.87 19.17 7.15 5.27

SMS Lifesciences India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.05 -4.26 1.59 10.29 13.36

Competitive Comparison of SMS Lifesciences India's Return-on-Tangible-Equity

For the Biotechnology subindustry, SMS Lifesciences India's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMS Lifesciences India's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SMS Lifesciences India's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where SMS Lifesciences India's Return-on-Tangible-Equity falls into.



SMS Lifesciences India Return-on-Tangible-Equity Calculation

SMS Lifesciences India's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=90.928/( (1685.369+1767.734 )/ 2 )
=90.928/1726.5515
=5.27 %

SMS Lifesciences India's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=236.168/( (0+1767.734)/ 1 )
=236.168/1767.734
=13.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


SMS Lifesciences India  (BOM:540679) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


SMS Lifesciences India Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of SMS Lifesciences India's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SMS Lifesciences India (BOM:540679) Business Description

Traded in Other Exchanges
Address
Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
SMS Lifesciences India Ltd is engaged in the Business of manufacturing of Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, and Erectile Dysfunction.

SMS Lifesciences India (BOM:540679) Headlines

No Headlines